Clinical trial Recruiting at 1 site Interventional Ages 25 to 65

See if CellCore protocols change environmental toxin biomarkers and health in adults

Official title: Prospective Human Study Evaluating Changes in Markers of Detoxification, Overall Physical and Mental Health, and Fatigue Following Supplementation With CellCore Protocols

Run by OvationLab · NCT07753798 · Data updated 2026-11-12

This study tests whether two CellCore protocols can modify urinary environmental toxicant levels and improve health in adults with high toxin exposure.

More General Health trials

Quick facts

Study typeInterventional
Ages25 Years to 65 Years
SexAll
Enrollment40 (estimated)
SponsorOvationLab
Research network
Locations1 site (Richmond, Virginia)
StatusRecruiting
StartedSeptember 28, 2026
Main results expectedJune 2027
Study endsJune 2027
Registry record updatedOctober 19, 2026
Trial IDNCT07753798 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 25–65 with elevated urinary toxicants (above the 75th percentile for at least five toxins) and specific PROMIS Global Health Physical Health criteria, under a participating clinician in the United States.

Probably not a fit

Individuals without elevated toxin biomarkers or who do not respond to the assigned protocol may not experience health benefits.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, open-label, single-arm study assigns adults with elevated urinary environmental toxicants to either the Foundational Protocol or the BioToxin Binder/Drainage Activator based on baseline health and fatigue. The trial measures changes in urinary toxicant biomarkers and patient-reported health outcomes before and after the intervention. Participants must be under the care of a qualified practitioner, live in the United States, and complete testing and questionnaires. The study is led by OvationLab in Richmond, VA, with no listed collaborators.

Why it matters

Potential benefit: If successful, the protocols could reduce toxin biomarkers and improve overall health metrics for participants.

How similar studies have gone: Existing data on similar detoxification approaches are limited and evidence is mixed; this trial explores a novel, protocol-based approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Adult between 25 and 65 years of age
2. Documented elevated urinary environmental toxicant levels above the 75th percentile of at least 5 toxins on baseline environmental toxin test
3. PROMIS - Global Health - Physical Health t-scores \< 42.4 for Foundational Protocol (otherwise BioToxin Binder/Drainage Activator Protocol)
4. Currently receiving care from a qualified, participating practitioner
5. Lives in the United States
6. Ability to speak and read English
7. Willing and able to follow the assigned CellCore protocols and complete all required testing and questionnaires
8. Willing and able to provide informed consent

Exclusion Criteria:

1. Currently undergoing active chelation therapy
2. Participation in a structured detoxification program within the prior 60 days, including use of activated charcoal, bentonite/zeolite clay, chlorella, cholestyramine
3. Ongoing occupational toxic exposure (e.g., working on golf course, dry cleaning facility) that cannot be reduced or controlled during the study period
4. Pregnancy or lactation, or planning pregnancy during the study period
5. Major comorbid medical condition requiring complex specialty management that, in the practitioners' clinical judgment, would interfere with safe study participation
6. Anticipated initiation of additional detoxification products, major dietary changes, or other significant co-interventions during the study period
7. Unable or unwilling to provide informed consent

Where it's running

  • OvationLab
    Richmond, Virginia, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.